EUVIMEDEUVIMED entdecken
Crossref

Cannabinoid content on product labels influences cannabis health perceptions

Joshua L Stanz iD, Benjamin O Ladd iD, Renee E Magnan iD

Annals of Behavioral Medicine · 2025

DOI: 10.1093/abm/kaaf046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Behavioral Medicine, 2025. Verfasst von Joshua L Stanz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Washington State University Vancouver, Vancouver, Washington 98686, United States. Hauptthemen laut MEDLINE: Dronabinol, Product Labeling, Cannabinoids, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 27 Literaturangaben. Gefördert von: WSU Psychology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabis use in the United States is increasing and research is needed to understand factors contributing to decisions to use. Features of cannabis product labels communicating product content may influence health perceptions and willingness to use.

Purpose

We tested how individuals who use cannabis respond to different cannabinoid content and the inclusion of a visual aid to communicate cannabinoid potency.

Method

We used a 3 (within-subjects: THC-dominant, CBD-dominant, and equal THC:CBD ratio) × 2 (between-subjects: numeric information vs numeric information plus visual aid) mixed experimental design administered online through Prolific.com.

Participants

(N = 431) evaluated cannabis product packages on perceived health harms and benefits and likelihood to purchase and use cannabis.

Results

Relative to other products, CBD-dominant products were evaluated as least harmful, most beneficial, and least likely to purchase or use (all Ps < 005; ds 0.10-0.68) while THC-dominant products were evaluated as most harmful, least beneficial, and most likely to purchase and use (all Ps < .02; ds 0.11-0.68). Perceptions did not vary based on the inclusion of a visual aid (Ps > .10). In a parallel mediation model, cannabinoid content was indirectly associated with likelihood to use through perceived benefits (b = −.14, CI = −.22, −.07) but not perceived harms (b = −.01, CI = −.04, .07).

Conclusions

Communicating about cannabinoid content could have intended and unintended consequences. Cannabinoid content contributed to product health perceptions and willingness to purchase and use; visual depictions of cannabinoid content did not. Perceived benefits of cannabis could be a valuable intervention target to reduce potential harm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronabinolProduct LabelingCannabinoidsHealth Knowledge, Attitudes, PracticeCannabisHumansMaleFemaleAdultYoung AdultAdolescentMiddle Aged

Stichwörter der Autor:innen

cannabinoid potencycannabisperceived benefitperceived harmproduct labeling

Substanzen

DronabinolCannabinoids

Autor:innen und Institutionen

  • Department of Psychology, Washington State University Vancouver, Vancouver, Washington 98686, United States.

ORCID-Profile: Joshua L Stanz, Benjamin O Ladd, Renee E Magnan

Förderung

  • WSU Psychology Department

Zitieren

APA

Stanz, J. L., Ladd, B. O., & Magnan, R. E. (2025). Cannabinoid content on product labels influences cannabis health perceptions. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/kaaf046

Vancouver

Stanz JL, Ladd BO, Magnan RE. Cannabinoid content on product labels influences cannabis health perceptions. Annals of Behavioral Medicine. 2025. doi:10.1093/abm/kaaf046

BibTeX
@article{Stanz2025,
  author = {Stanz, Joshua L and Ladd, Benjamin O and Magnan, Renee E},
  title = {Cannabinoid content on product labels influences cannabis health perceptions},
  journal = {Annals of Behavioral Medicine},
  year = {2025},
  doi = {10.1093/abm/kaaf046}
}
Kostenlos starten →